XSWX
MOVE
Market cap2.73bUSD
Oct 09, Last price
114.20CHF
1D
-0.35%
1Q
-16.52%
IPO
16.12%
Name
Medacta Group SA
Chart & performance
P/E
25.37
P/S
3.54
EPS
4.83
Div yield, %
0.60%
Shrs. gr., 5y
—
Rev. gr., 5y
17.87%
Revenues
688m
+16.54%
Net income
96m
+31.88%
CFO
154m
+43.41%
Dividend
May 07, 20261.1 CHF/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Medacta Group SA is a global developer, manufacturer, and distributor of specialized orthopedic and neurosurgical medical devices. Its operations span Europe, North America, Asia-Pacific, and other international markets. The firm provides advanced solutions, such as personalized kinematic models and cutting-edge 3D planning tools, designed to support a wide array of surgical procedures, including those for the hip, knee, shoulder, spine, and sports-related injuries. Established in 1958, Medacta maintains its corporate headquarters in Castel San Pietro, Switzerland.
Related entities
Subsidiaries
Medacta International SA
Key people
Alberto Siccardi
Non-Executive Chairman of the Board · since 2018
Francesco Siccardi
Chief Executive Officer, Member of the Group Executive Management. · since 2018
Lead Non-Executive Independent Director · since 2019
Headquarters & legal address
Strada Regina 34
Castel San Pietro, TI 6874
CH
Castel San Pietro, TI 6874
CH
Other language
Medacta Group AG
Other language
Medacta Group Ltd
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||